AltMountain

OrbiMed RCO IV Offshore Feeder, LP

New York, NY · CIK 1936776
Status: no Form D since Dec 2022. Funds file a Form D when they begin selling and amend it each year while the offering continues, so this fund has most likely stopped raising money. It may still be investing, or it may have closed or been dissolved. The details below are from its latest filing, kept here as a record.

OrbiMed RCO IV Offshore Feeder, LP is a private equity fund based in New York, New York. According to its most recent Form D, filed Dec 16, 2022, it has sold $344,450,400 of interests to 18 investors since its first sale in Jul 2022. The filing does not set a minimum investment. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include C. Stevens; Geoffrey Hsu; Carl Gordon.

Total raised
$344,450,400Cumulative sales reported on Form D
Investors
18
First sale
Jul 15, 2022
Minimum investment
None set
Who can invest
Qualified purchasersSection 3(c)(7): generally $5M+ in investments
Offering exemption
Rule 506(b)No general advertising
Key people and entities
C. Stevens; Geoffrey Hsu; Carl Gordon
Latest Form D
Dec 16, 2022

From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction⁠​​‌‌‌‌‌‌‌‌​​​​​​​​‌​⁠

Raise history

FiledFilingTotal raisedInvestorsSource
Dec 16, 2022Form D/A (amendment)$344,450,40018SEC.gov ↗
Jul 14, 2022Form D$00SEC.gov ↗

2 Form D filings in the SEC's electronic records (2008 onward), the earliest on Jul 14, 2022. Each filing reports the cumulative amount sold and the number of investors to that date, as the fund filed it. Not verified, and not the fund's current assets. Source: U.S. Securities and Exchange Commission, Form D data sets.

Questions about OrbiMed RCO IV Offshore Feeder, LP

What is the minimum investment for OrbiMed RCO IV Offshore Feeder, LP?

OrbiMed RCO IV Offshore Feeder, LP's latest Form D, filed Dec 16, 2022, does not set a minimum investment. Managers can still require one in the offering documents.

Who can invest in OrbiMed RCO IV Offshore Feeder, LP?

OrbiMed RCO IV Offshore Feeder, LP is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.

How much has OrbiMed RCO IV Offshore Feeder, LP raised?

OrbiMed RCO IV Offshore Feeder, LP reports $344,450,400 sold from 18 investors on its Form D filed Dec 16, 2022. This is cumulative sales since the offering began, not current assets or performance.

Where is OrbiMed RCO IV Offshore Feeder, LP based?

OrbiMed RCO IV Offshore Feeder, LP is based in New York, New York.

When did OrbiMed RCO IV Offshore Feeder, LP launch?

OrbiMed RCO IV Offshore Feeder, LP reports its first sale in Jul 2022.

Size compared with every private equity fund

Raised more than 88% of the 3,677 private equity funds based in New York, and more than 86% of all 9,002 that report sales.

Other funds with the same team

More private equity funds in New York

Similar-size private equity funds in New York

All private equity funds in New York